Application no. and date | 15702549.5 (espacenet) (Federated) (European Patent Register), 20150127 | Patent/reg. no. and date | DK/EP 3099307, 20171018 | Publication date | 20161207 | Priority no. and date | GB 201401465, 20140129 | EP pub. no. and date |
EP 3099307 20161207 | Effective date | | Applicant/owner | Chord Therapeutics SA, 15 Avenue de Sécheron
1202 Genève, CH | Applicant ref. no. | BT/GP/156326 | Inventor | ROACH, Arthur Henry, 10 route de Florissant
CH-1206 Geneva, CH, REJDAK, Konrad, Organowa 3/20
PL-20-882 Lublin, PL | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/7076 (2006.01) , A61K 38/21 (2006.01) , A61P 25/00 (2006.01) | Title | Anvendelse af cladribin til behandling af neuromyelitis optica | Int. application no. | GB2015050177 | Int. publication no. | WO2015114315 | Related patent (certificate) | | Status | Ændret DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|